zenodoopen
Evaluation of selected serum biomarkers levels in response to infliximab reference product (Remicade®) versus it's biosimilar (Remsima®) in a sample of ulcerative colitis patients: a cross-sectional study
<p><strong>Evaluation of selected serum biomarkers levels in response to infliximab reference product (Remicade</strong><sup>®</sup><strong>) versus it's biosimilar (Remsima</strong><sup>®</sup><strong>) in a sample of ulcerative colitis patients: a cross-sectional study</strong></p>
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 4
- Access
- 16
- Reuse readiness
- 0
- Engagement
- 0